Concepedia

Catherine Angwin

CA

Statistics

Publications

3

Citations

108

H-Index

3

Active since

2020

Affiliations

University of Glasgow(Current)

University of Exeter

University of Oxford

University of Dundee

Genomics (United Kingdom)

Catherine Angwin is an author at University of Glasgow specializing in type 2 diabetes treatment, medicine, and diabetes management.

Publications per year

2020–2022

3

Publications

3

Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

Beverley M. Shields, John Dennis, Catherine Angwin et al. · Nature Medicine · 2022 · 70 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol

Catherine Angwin, Caroline Jenkinson, Angus G. Jones et al. · BMJ Open · 2020 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Beverley M. Shields, Catherine Angwin, Maggie Shepherd et al. · Nature Medicine · 2022 · 19 citations · Full text

Medicine, Endocrinology, Internal Medicine +13

1–3 of 3